According to recently unveiled statistics by Future Market Insights, the global animal artificial insemination market is projected to exceed US$ 2.18 billion in 2023. Artificial insemination offers numerous advantages over natural breeding, such as improved genetic traits, disease control, and increased reproductive efficiency. Therefore, the market is anticipated to expand further and achieve US$ 3.91 billion by 2033, exhibiting a CAGR of 6.0% throughout the forecast period.
Artificial insemination (AI) allows farmers and breeders to access superior genetics and traits in animals. By using semen from high-quality sites, they can enhance the genetic characteristics of their livestock or animals, such as improved milk production, meat quality, disease resistance, or other desirable traits. The demand for such genetic improvements in livestock and other animals drives the need for artificial insemination services.
Artificial insemination provides a controlled and efficient method of reproductive management in animals. It allows breeders to synchronize the estrus cycle in females, accurately determine the timing of insemination, and optimize breeding programs. This level of control and management is crucial for maximizing reproductive efficiency, especially in large-scale farming operations.
AI plays a significant role in disease control and prevention in animals. By using semen from disease-free or disease-resistant sires, breeders can minimize the risk of transmitting genetic diseases or infections through natural mating. This is particularly important in the case of sexually transmitted diseases in livestock, where artificial insemination offers a safer alternative to natural breeding.
The global trade of livestock and genetics has increased significantly in recent years. AI facilitates the exchange of genetic material across borders by eliminating the need to transport live animals. It allows breeders to access superior genetics from different parts of the world, promoting genetic diversity and the development of improved animal breeds.
Technological advances have greatly improved the efficiency and success rates of artificial insemination. Innovations such as improved semen collection and processing techniques, better synchronization protocols, and advanced reproductive technologies like sexed semen have made AI more accessible and effective. These technological advancements attract more breeders and farmers to adopt AI as a preferred breeding method.
Artificial insemination offers several cost and convenience benefits compared to natural breeding. It eliminates the need for maintaining and housing many breeding animals, reduces the risk of injuries or accidents during mating, and enables breeders to optimize their resources and space. Additionally, artificial insemination allows breeders to access high-quality genetics at a fraction of the cost of purchasing and maintaining a live breeding animal.
With increasing environmental and sustainability concerns, artificial insemination can contribute to more efficient resource utilization. It helps reduce the overall carbon footprint associated with livestock production by optimizing breeding practices and reducing the number of breeding animals needed. Furthermore, AI can support the conservation of endangered or rare animal species by assisting in captive breeding programs.
Attribute | Details |
---|---|
Historical Value (2022) | US$ 2.07 billion |
Current Year Value (2023) | US$ 2.18 billion |
Expected Forecast Value (2033) | US$ 3.91 billion |
Projected CAGR (2023 to 2033) | 6.0% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Until recently, owing to the limited awareness about the advantages of artificial insemination techniques, the availability of the instruments, reagents, and media was fairly limited. According to Future Market Insights (FMI), the sales in the market increased at 4.6% CAGR between 2018 and 2022.
The increasing prevalence of contagious diseases among animals, the rise in meat consumption, and the demand for improving food security have compelled manufacturers to develop advanced products for veterinary hospitals, clinics, and animal breeders, which are the key end users.
The availability of advanced technologies for animal artificial breeding leads to the healthy birth of offspring capable of producing a high amount of proteins and dairy products. This is expected to positively impact animal artificial insemination market growth.
Contagious disease outbreaks can severely affect the livestock population and cause direct and indirect economic losses. Additionally, substantial resources are required to control disease outbreaks.
Government organizations, in collaboration with public organizations, have allocated mutual economic resources for artificial insemination techniques to prevent and control infectious diseases in livestock animals.
Precision breeding, also known as genomic selection, combines genetic information and advanced data analytics to select the best sires and dams for artificial insemination. This approach maximizes the chances of producing offspring with desired traits, resulting in higher productivity and profitability. Precision breeding is gaining popularity and driving the adoption of artificial insemination in the livestock industry.
Artificial insemination is considered a more humane and efficient breeding method than natural mating. It minimizes the risks associated with natural breeding, such as injuries and the transmission of diseases. As animal welfare concerns gain prominence, more farmers and breeders are adopting AI, driving the market growth.
Artificial insemination (AI) is a process originally developed to control the spread of such diseases by avoiding physical contact between animals. The use of AI products, such as semen extenders containing antibodies, helps prevent the transmission of bacterial diseases. This factor is also expected to have a positive impact on animal artificial insemination market growth. Hence, overall growth predictions remain positive for the market. According to FMI analysis, the market is likely to exhibit a 6.0% CAGR between 2023 and 2033.
Fresh semen volume, sperm quantity, and seminal plasma level at final dilution may affect the survivability of low sperm dosages. Low sperm dosages have lower quality and fertility, which is one of the drawbacks to their usage in successful artificial insemination techniques. To ensure optimal fertility, a certain number of sperm per artificial insemination is required. This is an important aspects of the artificial insemination industry and provides a scope of improvement in this space.
Increase in animal production has fueled the demand for animal health services to improve food safety systems and animal public health to protect human health. The acceptance of animal artificial insemination services, on the other hand, is strongly dependent on the country's economic, political, and institutional circumstances.
Governments from numerous nations, therefore, have joined forces to enhance public knowledge about animal diseases and the privatization of animal healthcare to encourage the adoption of animal artificial insemination services. Livestock Insurance is one such scheme in Europe, which was adopted to improve the effectiveness and efficiency of animal healthcare systems. Such strong government support is expected to have a positive impact on the adoption of advanced techniques such as animal artificial insemination.
Antibodies in the serum of breeding sires used for semen collection are routinely evaluated, as they are suggestive of any previous infection. Some viruses, such as the horse arteritis virus, can stay in the sperm for several weeks before showing signs of seroconversion
Semen from such animals can be a source of infections that can be transmitted to naive females. This is reducing demand and is projected to limit the global artificial insemination market's growth over the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Leading industry players such as Zoetis, Sanofi, and Boehringer Ingelheim, currently dominate the global animal insemination market. Among the products offered, reagents and media segments in the artificial insemination market account for higher revenue growth rates for all these key players.
On the other hand, the other AI products such as kits, catheters, sales are done primarily by small players such as continental Plastic Corporation, Swine Genetics Jorgensen Labs, which represents huge growth opportunities to capitalize on the opportunities in the instruments segment at regional as well as international markets.
Countries | 2022 Value Share in Global Market |
---|---|
United States | 93.8% |
Germany | 25.4% |
Japan | 46.2% |
In the United States, 80% of dairy animals were bred using AI technology. Such higher adoption of the animal artificial insemination (AI) techniques has made the United States one of the key animal artificial insemination markets. This trend is expected to continue to forecast period.
Market partnerships, collaborations, and agreements are some of the key trends adopted by the regional players to strengthen their foothold in the animal artificial insemination market. For instance, Elanco Animal Health, in April 2021, announced a partnership with Ducks Unlimited for strengthening environmental sustainability and agriculture – specifically for beef cattle production across North America.
The growing number of animal breeding facilities, technological advancements for animal artificial insemination, advantages associated with animal breeding with AI technologies, growing research, and development expenses are fueling the growth of the United States animal artificial insemination market during the forecast period.
Germany has a strong focus on genetic improvement in livestock breeding programs. The adoption of artificial insemination techniques has increased as it allows breeders to access superior genetics from a wider range of animals. This trend is particularly prominent in the dairy cattle, pig, and horse breeding sectors.
Germany has a well-established and highly-regarded breeding program infrastructure. The country has many specialized breeding centers and semen production units. Additionally, veterinary facilities are present to ensure the availability of high-quality semen. These facilities also offer advanced reproductive technologies.
The German government has implemented favorable policies and provided financial incentives to promote the use of artificial insemination techniques. These measures aim to improve animal genetics, enhance productivity, and ensure sustainable livestock farming practices.
The presence of leading players, technological advancements, growing consumption of animal protein, milk, and other dairy products are fueling the demand for genetically superior breed of animals. This is a key factor speeding the growth of the Germany animal artificial insemination market.
The Japan animal artificial insemination market is witnessing steady growth due to various factors, such as
Alongside artificial insemination, there is a growing interest in embryo transfer techniques in Japan. Embryo transfer allows for the production of multiple offspring from superior female animals, accelerating genetic progress within a shorter time frame.
Japan is known for its technological advancements, and the animal artificial insemination sector is no exception. The animal artificial insemination market is witnessing the adoption of advanced technologies, such as computer-assisted semen analysis, automated semen collection systems, and precise synchronization protocols, improving the overall efficiency and success rates of artificial insemination.
Japan has a strong cultural affinity toward high-quality and well-bred livestock. There is a demand for specific breeds, and artificial insemination allows farmers to access genetics from around the world. This cultural preference for superior livestock has contributed to the growth of the animal artificial insemination market.
Countries | Value CAGR (2023 to 2033) |
---|---|
United Kingdom | 5.5% |
China | 9.7% |
India | 8.5% |
The demand for high-quality breeds is increasing, which, in turn, is expected to boost the demand for the artificial animal insemination process. Considering the high demand, various industrial developmental activities in the region are taking place. This is expected to positively influence the growth of the animal artificial insemination market in the United Kingdom.
AB Europe, For instance, collaborated with Cogent in August 2020 to provide sexed sheep semen services to sheep producers in the United Kingdom. This service enables producers to obtain a higher quality breed and increase the sheep population. Additionally, in February 2020, United Kingdom Sires Services entered into a partnership with IntelliGen Technologies to offer sexed semen services for United Kingdom bull owners. This partnership intends to help maximize the potential of their breeding programs.
The active participation of industry leaders in providing animal services, therefore, is expected to have a positive influence on market growth.
The China animal artificial insemination market in China has witnessed significant growth in recent years due to
China has witnessed the growing adoption of advanced reproductive technologies, including artificial insemination (AI), to improve livestock breeding efficiency and genetic quality. AI offers advantages such as disease control, better genetic diversity, and increased production potential.
Livestock breeders in China are becoming more aware of the benefits of artificial insemination in terms of disease prevention, reproductive performance, and overall animal health. This awareness is driving the adoption of AI techniques across various animal species.
China has a vast livestock population, including pigs, cattle, sheep, and poultry. This provides a significant market potential for artificial insemination services and products as breeders seek to enhance the genetic quality and productivity of their animals.
With the growth of the middle class and increasing disposable incomes, there is a rising demand for high-quality animal products in China, such as dairy, meat, and poultry. Artificial insemination helps meet this demand by improving livestock genetics and enhancing production efficiency.
The government has recognized the importance of advanced breeding techniques for developing the animal husbandry sector. It has introduced supportive policies, subsidies, and incentives to encourage the adoption of artificial insemination and other reproductive technologies.
Among the South East Asian countries, India is expected to account for the larger share of the market. Significant support in the form of funding and rolling out new reforms to conserve the local indigenous breed of cattle are driving animal artificial insemination market growth in emerging economies such as India.
One such example is Madhya Pradesh (MP), which ranks second after Telangana in the adoption of the AI process. In MP, every hour 70 cows are being impregnated through artificial insemination (AI) to improve the genetic superiority of the animals.
As Per the Government of India, Telangana led the country with 2, 49,819 AIs from September 2019 to March 2020. Also, other states such as Uttar Pradesh had one of the highest numbers of AIs of about 1, 44,039 conducted during the same period. Such strong support from the government is expected to provide a positive impetus for the growth of the India animal artificial insemination market through 2033.
Segment | Forecasted CAGR (2023 to 2033) |
---|---|
Reagent Media | 27.54% |
Ruminant | 23.28% |
Semen Collection Procedures | 71.8% |
Animal Hospitals | 46.5% |
Reagent media plays a crucial role in animal artificial insemination procedures. Reagent media are commonly used for the preservation and storage of spermatozoa. These media help maintain the quality and viability of sperm cells during cryopreservation or storage for future use.
Farmers and ranchers need to purchase reagent media on a regular basis to maintain their artificial insemination programs. This recurring revenue stream helps to drive sales for the reagent media segment.
Semen culture is a process of artificially stimulating the growth of sperm cells in a laboratory setting. This process can help to improve the quality and viability of sperm cells, which can lead to increased pregnancy rates. As the use of semen culture becomes more widespread, the demand for reagent media is also expected to increase.
A relatively higher adoption of reagent media is witnessed owing to their recurrent purchase. Also, the growing importance of semen culture is driving the sales of this product segment. Reagent media is a consumable product that needs to be replaced regularly. This leads to a higher adoption rate of reagent media than other products in the market.
Ruminants accounted for the leading share of the global artificial insemination market. The rising in consumption of animal proteins, milk, and milk products is a key factor attributable for the larger share of the segment.
Ruminants, particularly cattle, play a crucial role in the agricultural industry. They are a significant source of milk, meat, and other by-products, making them economically valuable. The demand for improved genetics in ruminant breeding to enhance productivity and quality of offspring is high, leading to greater adoption of AI technologies.
AI in ruminants is relatively easier to perform compared to other species. The reproductive anatomy of ruminants, particularly cattle, allows for the straightforward collection and deposition of semen. Additionally, the synchronization of estrus (heat) cycles is easier in ruminants, enabling better control over breeding schedules and optimizing the use of AI.
United Nation (UN) Food and Agriculture Organization (FAO) states that beef and buffalo production increased from 69.5 million ton in 2017 to 71.6 million tons in 2018. Also, consumption of milk and milk products has increased. Organization for Economic Co-operation and Development (OECD) and UN FAO also stated that, in 2020, the global per capita dairy consumption was estimated at 113.7 kg, and this number is expected to rise by 44% by 2029.
Semen collection procedure leads the animal artificial insemination market in terms of the type of procedures. Demand for genetic improvement in the cattle population has led to the adoption of advanced semen collection procedures. This is expected to have a positive impact on the market growth.
Semen plays a crucial role in artificial insemination as it contains the sperm needed to fertilize the female animal. Collecting high-quality semen from superior male animals ensures genetic improvement and enables the propagation of desirable traits in the offspring. Semen collection procedures, therefore, form the foundation of successful artificial insemination programs.
Semen collection allows for the preservation of genetic material from valuable male animals, including those that may have passed away or are no longer available for breeding. This preservation ensures the availability of superior genetic material for future use, promoting genetic diversity and breeding programs.
Artificial insemination using semen collected from superior males can be more cost-effective compared to natural breeding methods. It allows breeders to access genetics from top-performing animals without the need to transport those animals to different locations for breeding purposes. Semen can also be stored and transported more easily, reducing the costs associated with maintaining and managing live animals.
The rising number of animal artificial insemination being conducted in anima hospitals in developed countries has led this segment to accounting for the leading market share. Also, the rise in number of veterinary practitioners/physicians is also contributing to the growth of this end user segment.
Animal hospitals often have specialized veterinary professionals with expertise in reproductive medicine and artificial insemination techniques. They possess the necessary equipment, facilities, and infrastructure required for performing artificial insemination procedures on animals.
Animal hospitals are expected to maintain high safety and quality standards in their procedures and protocols. They adhere to regulatory guidelines and ensure the use of appropriate techniques, sanitary conditions, and health monitoring, which can be crucial in the artificial insemination process.
In cases where animals require additional medical intervention or have specific reproductive challenges, such as fertility issues or genetic concerns, animal hospitals are better equipped to provide specialized care. They can offer advanced reproductive technologies, such as in vitro fertilization (IVF) or embryo transfer, in conjunction with artificial insemination.
Key players in animal artificial insemination market typically employ several strategies to maintain a competitive edge and expand their market presence. These strategies include:
Recent Developments by Key Animal Artificial Insemination Market Players
By 2023, the market is valued at US$ 2.18 billion.
The market will expand at a 6% CAGR through 2033.
From 2018 to 2022, the market expanded at a 4.6% CAGR.
Semen contamination may impede future market growth.
Zoetis, Sanofi, and Boehringer Ingelheim are key players.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product type, 2023 to 2033
5.3.1. Insemination Equipment
5.3.1.1. Catheters
5.3.1.2. Micromanipulation Pipettes
5.3.1.3. Insemination Gun
5.3.2. Artificial Insemination Syringe
5.3.3. Insemination Sheath
5.3.4. Artificial Insemination Applicator
5.3.5. Reagent Media
5.3.5.1. Bovine Media
5.3.5.2. Equine Media
5.3.5.3. IVF Media
5.3.6. Thawer
5.3.7. Accessories
5.3.8. Artificial Insemination Kits
5.3.9. Others
5.4. Y-o-Y Growth Trend Analysis By Product type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Animal Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Animal Type, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Animal Type, 2023 to 2033
6.3.1. Canine
6.3.2. Feline
6.3.3. Swine
6.3.4. Bovine
6.3.5. Equine
6.3.6. Ruminant
6.4. Y-o-Y Growth Trend Analysis By Animal Type, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Animal Type, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Procedure Type
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis by Procedure Type, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast by Procedure Type, 2023 to 2033
7.3.1. Semen Collection Procedures
7.3.1.1. Artificial Vagina
7.3.1.2. Electrostimulation
7.3.2. Insemination Procedures
7.3.2.1. Recto Vaginal
7.3.2.2. Spectrum
7.3.2.3. Vaginal
7.4. Y-o-Y Growth Trend Analysis by Procedure Type, 2018 to 2022
7.5. Absolute $ Opportunity Analysis by Procedure Type, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End Users
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By End Users, 2018 to 2022
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End Users, 2023 to 2033
8.3.1. Animal Hospitals
8.3.2. Animal Clinics
8.3.3. Animal Breeding Centers
8.3.4. Others
8.4. Y-o-Y Growth Trend Analysis By End Users, 2018 to 2022
8.5. Absolute $ Opportunity Analysis By End Users, 2023 to 2033
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. South Asia
9.3.5. East Asia
9.3.6. Oceania
9.3.7. MEA
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. The USA
10.2.1.2. Canada
10.2.2. By Product type
10.2.3. By Animal Type
10.2.4. By Procedure Type
10.2.5. By End Users
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product type
10.3.3. By Animal Type
10.3.4. By Procedure Type
10.3.5. By End Users
10.4. Key Takeaways
11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Product type
11.2.3. By Animal Type
11.2.4. By Procedure Type
11.2.5. By End Users
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product type
11.3.3. By Animal Type
11.3.4. By Procedure Type
11.3.5. By End Users
11.4. Key Takeaways
12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. United Kingdom
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Rest of Europe
12.2.2. By Product type
12.2.3. By Animal Type
12.2.4. By Procedure Type
12.2.5. By End Users
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product type
12.3.3. By Animal Type
12.3.4. By Procedure Type
12.3.5. By End Users
12.4. Key Takeaways
13. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Malaysia
13.2.1.3. Singapore
13.2.1.4. Thailand
13.2.1.5. Rest of South Asia
13.2.2. By Product type
13.2.3. By Animal Type
13.2.4. By Procedure Type
13.2.5. By End Users
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product type
13.3.3. By Animal Type
13.3.4. By Procedure Type
13.3.5. By End Users
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Product type
14.2.3. By Animal Type
14.2.4. By Procedure Type
14.2.5. By End Users
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product type
14.3.3. By Animal Type
14.3.4. By Procedure Type
14.3.5. By End Users
14.4. Key Takeaways
15. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. Australia
15.2.1.2. New Zealand
15.2.2. By Product type
15.2.3. By Animal Type
15.2.4. By Procedure Type
15.2.5. By End Users
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product type
15.3.3. By Animal Type
15.3.4. By Procedure Type
15.3.5. By End Users
15.4. Key Takeaways
16. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
16.2.1. By Country
16.2.1.1. GCC Countries
16.2.1.2. South Africa
16.2.1.3. Israel
16.2.1.4. Rest of MEA
16.2.2. By Product type
16.2.3. By Animal Type
16.2.4. By Procedure Type
16.2.5. By End Users
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Product type
16.3.3. By Animal Type
16.3.4. By Procedure Type
16.3.5. By End Users
16.4. Key Takeaways
17. Key Countries Market Analysis
17.1. USA
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2022
17.1.2.1. By Product type
17.1.2.2. By Animal Type
17.1.2.3. By Procedure Type
17.1.2.4. By End Users
17.2. Canada
17.2.1. Pricing Analysis
17.2.2. Market Share Analysis, 2022
17.2.2.1. By Product type
17.2.2.2. By Animal Type
17.2.2.3. By Procedure Type
17.2.2.4. By End Users
17.3. Brazil
17.3.1. Pricing Analysis
17.3.2. Market Share Analysis, 2022
17.3.2.1. By Product type
17.3.2.2. By Animal Type
17.3.2.3. By Procedure Type
17.3.2.4. By End Users
17.4. Mexico
17.4.1. Pricing Analysis
17.4.2. Market Share Analysis, 2022
17.4.2.1. By Product type
17.4.2.2. By Animal Type
17.4.2.3. By Procedure Type
17.4.2.4. By End Users
17.5. Germany
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2022
17.5.2.1. By Product type
17.5.2.2. By Animal Type
17.5.2.3. By Procedure Type
17.5.2.4. By End Users
17.6. United Kingdom
17.6.1. Pricing Analysis
17.6.2. Market Share Analysis, 2022
17.6.2.1. By Product type
17.6.2.2. By Animal Type
17.6.2.3. By Procedure Type
17.6.2.4. By End Users
17.7. France
17.7.1. Pricing Analysis
17.7.2. Market Share Analysis, 2022
17.7.2.1. By Product type
17.7.2.2. By Animal Type
17.7.2.3. By Procedure Type
17.7.2.4. By End Users
17.8. Spain
17.8.1. Pricing Analysis
17.8.2. Market Share Analysis, 2022
17.8.2.1. By Product type
17.8.2.2. By Animal Type
17.8.2.3. By Procedure Type
17.8.2.4. By End Users
17.9. Italy
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2022
17.9.2.1. By Product type
17.9.2.2. By Animal Type
17.9.2.3. By Procedure Type
17.9.2.4. By End Users
17.10. India
17.10.1. Pricing Analysis
17.10.2. Market Share Analysis, 2022
17.10.2.1. By Product type
17.10.2.2. By Animal Type
17.10.2.3. By Procedure Type
17.10.2.4. By End Users
17.11. Malaysia
17.11.1. Pricing Analysis
17.11.2. Market Share Analysis, 2022
17.11.2.1. By Product type
17.11.2.2. By Animal Type
17.11.2.3. By Procedure Type
17.11.2.4. By End Users
17.12. Singapore
17.12.1. Pricing Analysis
17.12.2. Market Share Analysis, 2022
17.12.2.1. By Product type
17.12.2.2. By Animal Type
17.12.2.3. By Procedure Type
17.12.2.4. By End Users
17.13. Thailand
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2022
17.13.2.1. By Product type
17.13.2.2. By Animal Type
17.13.2.3. By Procedure Type
17.13.2.4. By End Users
17.14. China
17.14.1. Pricing Analysis
17.14.2. Market Share Analysis, 2022
17.14.2.1. By Product type
17.14.2.2. By Animal Type
17.14.2.3. By Procedure Type
17.14.2.4. By End Users
17.15. Japan
17.15.1. Pricing Analysis
17.15.2. Market Share Analysis, 2022
17.15.2.1. By Product type
17.15.2.2. By Animal Type
17.15.2.3. By Procedure Type
17.15.2.4. By End Users
17.16. South Korea
17.16.1. Pricing Analysis
17.16.2. Market Share Analysis, 2022
17.16.2.1. By Product type
17.16.2.2. By Animal Type
17.16.2.3. By Procedure Type
17.16.2.4. By End Users
17.17. Australia
17.17.1. Pricing Analysis
17.17.2. Market Share Analysis, 2022
17.17.2.1. By Product type
17.17.2.2. By Animal Type
17.17.2.3. By Procedure Type
17.17.2.4. By End Users
17.18. New Zealand
17.18.1. Pricing Analysis
17.18.2. Market Share Analysis, 2022
17.18.2.1. By Product type
17.18.2.2. By Animal Type
17.18.2.3. By Procedure Type
17.18.2.4. By End Users
17.19. GCC Countries
17.19.1. Pricing Analysis
17.19.2. Market Share Analysis, 2022
17.19.2.1. By Product type
17.19.2.2. By Animal Type
17.19.2.3. By Procedure Type
17.19.2.4. By End Users
17.20. South Africa
17.20.1. Pricing Analysis
17.20.2. Market Share Analysis, 2022
17.20.2.1. By Product type
17.20.2.2. By Animal Type
17.20.2.3. By Procedure Type
17.20.2.4. By End Users
17.21. Israel
17.21.1. Pricing Analysis
17.21.2. Market Share Analysis, 2022
17.21.2.1. By Product type
17.21.2.2. By Animal Type
17.21.2.3. By Procedure Type
17.21.2.4. By End Users
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Product type
18.3.3. By Animal Type
18.3.4. By Procedure Type
18.3.5. By End Users
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. Elanco Animal Health
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.2. Boehringer Ingelheim
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.3. Zoetis Inc.
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.4. Merck & Co., Inc.
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.5. Swine Genetics International
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.6. Revival Animal Health Inc.
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.7. Jorgensen Laboratories Inc.
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.8. Agtech Inc.
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.9. ABS Global, Inc.
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.10. Continental Plastic Corporation
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
19.1.11. IVM Technologies
19.1.11.1. Overview
19.1.11.2. Product Portfolio
19.1.11.3. Profitability by Market Segments
19.1.11.4. Sales Footprint
19.1.11.5. Strategy Overview
19.1.11.5.1. Marketing Strategy
20. Assumptions & Acronyms Used
21. Research Methodology
Explore Healthcare Insights
View Reports